Validation of knowledge and adherence assessment tools among patients on warfarin therapy in a Saudi hospital anticoagulant clinic

Larsen T, Skjøth F, Nielsen P, Kjældgaard J, Lip G. Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study. BMJ. 2016;353:i3189.

Alquwaizani M, Buckley L, Adams C, Fanikos J. Anticoagulants: a review of the pharmacology, dosing, and complications. Curr Emerg Hosp Med Rep. 2013;1(2):83–97.

Gurwitz J, Field T, Radford M, Harrold L, Becker R, Reed G, et al. The safety of warfarin therapy in the nursing home setting. Am J Med. 2007;120(6):539–44.

Abe J, Umetsu R, Kato Y, Ueda N, Nakayama Y, Suzuki Y, et al. Evaluation of dabigatran- and warfarin-associated hemorrhagic events using the FDA-adverse event reporting system database stratified by age. Int Med Sci. 2015;12(4):312–21.

Seet R, Rabinstein A, Christianson T, Petty G, Brown R. Bleeding complications associated with warfarin treatment in ischemic stroke patients with atrial fibrillation: a population-based cohort study. J Stroke Cerebrovasc Dis. 2013;22(4):561–9.

Alyousif S, Alsaileek A. Quality of anticoagulation control among patients with atrial fibrillation: an experience of a tertiary care center in Saudi Arabia. J Saudi Heart Assoc. 2016;28(4):239–43.

Carrasco-Garrido P, de Andrés L, Barrera V, de Miguel G, Jiménez-García R. Trends of adverse drug reactions related-hospitalizations in Spain (2001–2006). BMC Health Serv Res. 2010;10(1):287.

Sudlow C, Rodgers H, Kenny R, Thomson R. How to do it: service provision and use of anticoagulants in atrial fibrillation. BMJ. 1995;311:558–60.

Taylor F, Ramsay M, Renton A, Cohen H. Methods for managing the increased workload in anticoagulant clinics [letter]. BMJ. 1996;312:286.

Testa S, Zimmermann A, Cancellieri E, Bassi L, Paoletti O. Telemedicine for managing patients on oral anticoagulant therapy. In: Graschew G, Rakowsky S, editors. Telemedicine techniques and applications. 2014. ISBN: 978-953-307-354-5. www.intechopen.com .

Dib J, Mohammed K, Momattin H, Alshehri A. Implementation of pharmacist-managed anticoagulation clinic in a Saudi Arabian health center. Hosp Pharm. 2014;49(3):260–8.

Mayet A. Association between oral anticoagulation knowledge, anticoagulation control, and demographic characteristics of patients attending an anticoagulation clinic in Saudi Arabia: a cross-sectional prospective evaluation. Trop J Pharm Res. 2015;14(7):1285–91.

Mayet A. Patient adherence to warfarin therapy and its impact on anticoagulation control. Saudi Pharm J. 2016;24(1):29–34.

Bayoumy NM, Al-Omair SF, Musallam NA, Al-Deghaither NY, Al-Sadoun NA. Compliance with and awareness about long-term oral anticoagulant therapy among Saudi patients in a university hospital, Riyadh, Saudi Arabia. J Appl Hematol. 2016;7(1):10–6.

Elbur A, Albarraq A, Maugrabi M, Alharthi S. Knowledge of, satisfaction with and adherence to oral anticoagulant drugs among patients in King Fasial Hospital. Int J Pharm Sci Rev Res. 2015;31(1):274–80.

Matchar D, Jacobson A, Dolor R, Edson R, Uyeda L, Phibbs C, et al. Effect of home testing of international normalized ratio on clinical events. N Engl J Med. 2010;363(17):1608–20.

Wofford J, Wells MD, Singh S. Best strategies for patient education about anticoagulation with warfarin: a systematic review. BMC Health Serv Res. 2008;8:40.

Katusiime B, Corlett S, Reeve J, Krska J. Measuring medicine-related experiences from the patient perspective: a systematic review. Patient Relat Outcome Meas. 2016;7:157–71.

Nasser S, Mullan J, Bajorek B. Challenges of older patients’ knowledge about warfarin therapy. J Prim Care Commun Health. 2012;3(1):65–74.

Cook DA, Beckman TJ. Current concepts in validity and reliability for psychometric instruments: theory and application. Am J Med. 2006;119(2):166.e7–16.

Zeolla M. Development and validation of an instrument to determine patient knowledge: the oral anticoagulation knowledge test. Ann Pharmacother. 2006;40(4):633–8.

Briggs A, Jackson T, Bruce S, Shapiro N. The development and performance validation of a tool to assess patient anticoagulation knowledge. Res Social Adm Pharm. 2005;1(1):40–59.

Khudair I, Hanssens Y. Evaluation of patients’ knowledge on warfarin in outpatient anticoagluant clinics in a teaching hosiptal in Qatar. Saudi Med J. 2010;31(6):672–7.

Morisky D, Green L, Levine D. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74.

Wang Y, Kong M, Ko Y. Comparison of three medication adherence measures in patients taking warfarin. J Thromb Thrombolysis. 2013;36(4):416–21.

Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–97.

Glanz K, Scholl TO. Intervention strategies to improve adherence among hypertensives: review and recommendations. Patient Couns Health Educ. 1982;4(1):14–28.

Sweileh W, Aker O, Hamooz S. Rate of compliance among patients with diabetes mellitus and hypertension. An-Najah Univ J Res. (N. Sc.). 2005;19(1):1–11.

Jamous R, Sweileh W, Abu-Taha A, Sawalha A, Zyoud S, Morisky D. Adherence and satisfaction with oral hypoglycemic medications: a pilot study in Palestine. Int J Clin Pharm. 2011;33(6):942–8.

Morisky D, Ang A, Krousel-Wood M, Ward H. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens. 2008;10(5):348–54.

Wang Y, Kong M, Ko Y. Psychometric properties of the 8-item Morisky Medication Adherence Scale in patients taking warfarin. Thromb Haemost. 2012;108(4):789–95.

Schulman S, Kearon C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost. 2005;3(4):692–4.

Hirsh J, Dalen J, Anderson D, Poller L, Bussey H, Ansell J, et al. Oral Anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest. 2001;119:8S–21S.

Konishi H, Miyauchi K, Kasai T, Tsuboi S, Ogita M, Naito R, et al. Adequate time in therapeutic INR range using triple antithrombotic therapy is not associated with long-term cardiovascular events and major bleeding complications after drug-eluting stent implantation. J Cardiol. 2016;68(6):517–22.

Rosendaal F, Cannegieter S, Van der Meer F, Briet E. A Method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost. 1993;69(3):236–9.

Rose A, Berlowitz D, Frayne S, Hylek E. Measuring Quality of Oral Anticoagulation care: extending quality measurement to a new field. Jt Comm J Qual Patient Saf. 2009;35(3):146–55.

Sargent R, Brocklebank C, Tam-Tham H, Williamson T, Quail P, Turner D, et al. Advantages of a warfarin protocol for long-term care pharmacists: a retrospective cohort study. Can Geriatr J. 2016;19(2):40–9.

Verhovsek M, Motlagh B, Crowther M, Kennedy C, Dolovich L, Campbell G, et al. Quality of anticoagulation and use of warfarin-interacting medications in long-term care: a chart review. BMC Geriatr. 2008;8:13.

Davis N, Billett H, Cohen H, Arnsten J. Impact of adherence, knowledge, and quality of life on anticoagulation control. Ann Pharmacother. 2005;39(4):632–6.

Esmerio F, Souza E, Leiria T, Lunelli R, Moraes M. Constant use of oral anticoagulants: implications in the control of their adequate levels. Arq Bras Cardiol. 2009;93(5):549–54.

Ryals C, Pierce K, Baker J. INR Goal attainment and oral anticoagulation knowledge of patients enrolled in an anticoagulation clinic in a veterans affairs medical center. J Manag Care Pharm. 2011;17(2):133–42.

Barcellona D, Contu P, Marongiu F. Patient education and oral anticoagulant therapy. Haematologica. 2002;87(10):1081–6.

Matalqah L, Radaideh K, Sulaiman S, Hassali M, Abdul Kader M. Relationship between patients’ warfarin knowledge and anticoagulation control: results of a validated tool in Malaysia. J Pharm Biomed Sci. 2013;30(30):967–74.

Kimmel S, Chen Z, Price M, Parker C, Metlay J, Christie J, et al. The Influence of patient adherence on anticoagulation control with warfarin. Arch Intern Med. 2007;167(3):229–35.

Nguyen TM, La Caze A, Cottrell N. What are validated self-report adherence scales really measuring? A systematic review. Br J Clin Pharmacol. 2014;77(3):427–45.

Stirratt MJ, Dunbar-Jacob J, Crane HM, Simoni JM, Czajkowski S, Hilliard ME, et al. Self-report measures of medication adherence behavior: recommendations on optimal use. Transl Behav Med. 2015;5(4):470–82.